TianYu Bio-Technology Co., Ltd. (603717.SS) SHH

Currency In CNY

AD

Valuation

Market Cap2.27B
Enterprise Value3.31B
P/E Ratio-10.24
PEG Ratio0.2
Price/Sales Ratio2.64
Price/Book Ratio5.17
Enterprise/Revenue4.01
Enterprise/EBITDA-17.41

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.26
Operating Margin-0.32
AD

Management Effectiveness

Return On Assets-0.06
Return On Equity-0.42

Income Statement

Revenue724.32M
Revenue/Share2.29
Gross Profit-12.35M
EBITDA-61.63M
Net Income-106.9M
Diluted EPS-0.37

Balance Sheet

Total Cash135.31M
Total Cash/Share0.47
Total Debt1.05B
Total Debt/Equity3.1
Current Ratio0.9
Book Value Per Share1.87

Price History

52-Week Change-38.53
52-Week High11.17
52-Week Low4.74
Moving Average 50 Days6.14
Moving Average 200 Days6.99

Statistics

Average Volume15.08M
Shares Outstanding290.15M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.15
Last Split Factor7:5
Last Split DateJune 08, 2018
AD